Sit Investment Associates Inc Astrazeneca PLC Transaction History
Sit Investment Associates Inc
- $4.41 Billion
- Q4 2024
A detailed history of Sit Investment Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Sit Investment Associates Inc holds 166,850 shares of AZN stock, worth $12.6 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
166,850
Previous 239,900
30.45%
Holding current value
$12.6 Million
Previous $18.7 Million
41.51%
% of portfolio
0.25%
Previous 0.42%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...